Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 8, 2026

4 hours ago

NeOnc' Phase 2 Data Could Put Cancer on the Ropes

Indeterminate GlobeNewswire

4 hours ago

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

Indeterminate GlobeNewswire

4 hours ago

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

Indeterminate GlobeNewswire

4 hours ago

Bone Biologics Expands Trial Sites

Indeterminate GlobeNewswire

4 hours ago

Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer

Indeterminate GlobeNewswire

4 hours ago

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

4 hours ago

Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy

Indeterminate GlobeNewswire

4 hours ago

Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel

Indeterminate GlobeNewswire

4 hours ago

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

4 hours ago

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Indeterminate GlobeNewswire

4 hours ago

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

4 hours ago

Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

4 hours ago

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

Indeterminate GlobeNewswire

4 hours ago

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Indeterminate GlobeNewswire

4 hours ago

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

4 hours ago

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

5 hours ago

Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director

Indeterminate GlobeNewswire

5 hours ago

CPTx appoints Matt Kane as Chief Financial Officer

Indeterminate GlobeNewswire

5 hours ago

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

5 hours ago

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire